Products for Research Use Only
RegisterLogin

SKLB-03220

CAT: 0013-GTR19257669-01Size: 1 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0013-GTR19257669-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
SKLB-03220 is an orally bioavailable covalent inhibitor targeting the histone methyltransferase EZH2, an established oncology drug target involved in epigenetic regulation. SKLB-03220 is structurally based on the clinically approved EZH2 inhibitor tazemetostat and demonstrates the ability to abolish epigenetic H3K27me3 marks, thereby altering chromatin state and transcriptional activity. SKLB-03220 represents a potent small-molecule tool for cancer epigenetics research.
CAS Number
2852050-29-2
Product Name Alternative
SKLB03220, Sklb-03220
Field of Research
Epigenetics & Chromatin
Purity
97.01% (May vary between batches)
Smiles
O=C (C=C) NC1=CC=C (C (=C1) C=2C=C (C (=O) NCC=3C (=O) NC (=CC3C) C) C (=C (C2) N (CC) C4CCOCC4) C) C
Molecular Formula
C33H40N4O4
Molecular Weight
556.71
Storage Conditions
-20°C
Notes
For research use only.

Related Products

CatalogName
GTR19280539-01SKLB-0124
GTR19258231-01SKLB-D18
GTR19158279-01SKLB-23bb
GTR19231918SKLB-03176
GTR19192622-01SKLB 1028
GTR19272971-01SKLB-Y13
GTR19263351-01SKLB-11A
GTR19173677-01SKLB-163
GTR19173145-01SKLB 610
GTR19186318-01SKLB-197

Alternative Products

CatalogName
T207811-01SKLB-03220
TRC-S555010-250MGSKLB-1028
QXC58006-01SKLB-23bb
T34656-01SKLB 1028
BUP10703-01SKLB 610
M27829-01SKLB-163
C03652-1gSKLB-11A
C01495-5mgSKLB-197
HY-122860SKLB-C05

Popular Products